苏州麦迪斯顿医疗科技股份有限公司 关于使用部分闲置募集资金进行现金管理赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第四届董事会第三十一次会议、第四届监事会第十五次会议，审议通 过了《关于使用部分闲置募集资金进行现金管理的议案》，同意公司在确保不影 响募集资金投资项目进度和募集资金安全的前提下，对暂时闲置的部分募集资金 不超过人民币 2 亿元（包含本数）进行现金管理，余额在上述额度内，资金可以 滚动使用，用于购买单笔期限最长不超过 12 个月（含 12 个月）的结构性存款等 安全性高的保本型产品，不得用于证券投资。公司董事会、监事会及保荐机构已 分别对前述事项发表了同意的意见。具体内容详见公司于 2025 年 4 月 30 日披露 的《关于使用部分闲置募集资金进行现金管理的公告》(公告编号：2025-025)。 一、 公司募集资金现金管理到期赎回情况 公司于 2025 年 12 月 31 日向浙商银行苏州分行营业部办理了银行 ...

Group 1 - The core point of the article is that Mr. Weng Kang has reduced his shareholding in Suzhou Medistone Medical Technology Co., Ltd. by 520.29 million shares, which triggered a 1% change in equity [1] - Before the reduction, Mr. Weng held 20.857 million shares, and after the reduction, he holds 15.6541 million shares [1] - The share reduction occurred between October 16, 2025, and January 12, 2026, through centralized bidding and block trading methods [1]

Group 1 - On January 12, 2026, Madi Technology executed a block trade of 2.1513 million shares, with a total transaction value of 30.5485 million yuan, accounting for 5.62% of the total trading volume for that day [1] - The transaction price was 14.2 yuan, representing an 11.53% discount compared to the market closing price of 16.05 yuan [1] - The block trade involved multiple institutional buyers, indicating strong interest from institutional investors [2][3] Group 2 - The trading data shows that the transaction price remained consistent at 14.2 yuan across various trades on the same day [2][3] - The total transaction amounts for different institutional buyers varied, with the highest being 873.3 thousand yuan [3] - The involvement of specialized institutional trading departments suggests a strategic approach to acquiring shares at a discounted price [2][3]

Core Viewpoint - The report highlights a significant outflow of main capital from various stocks in the Shanghai and Shenzhen markets, with 387 stocks experiencing net outflows for five consecutive days or more, indicating potential investment risks in these companies [1][2][3][4]. Group 1: Main Capital Outflow Statistics - The stock with the longest continuous net outflow is Dameng Data, with 23 days of outflows [1]. - Daqin Railway follows with 20 days of net outflows, totaling 2.711 billion yuan [1]. - The total net outflow for Daqin Railway over 20 days is the highest at 2.711 billion yuan, while Xiechuang Data has a net outflow of 1.914 billion yuan over five days [1][2]. Group 2: Stocks with Significant Outflows - The top stocks by net outflow duration include: - Daqin Railway: 20 days, 2.711 billion yuan, 18.68% of trading volume, -6.22% cumulative change [1]. - Dameng Data: 23 days, 0.503 billion yuan, 7.58% of trading volume, 14.15% cumulative change [2]. - Haima Automobile: 12 days, 1.626 billion yuan, 8.26% of trading volume, -18.59% cumulative change [1]. Group 3: Other Notable Stocks - Other stocks with notable outflows include: - Wuzhou Xinchun: 5 days, 1.574 billion yuan, 5.24% of trading volume, 11.62% cumulative change [1]. - Dongshan Precision: 6 days, 1.512 billion yuan, 6.91% of trading volume, -6.80% cumulative change [1]. - Shengtai Electronics: 10 days, 1.377 billion yuan, 8.47% of trading volume, -8.71% cumulative change [1].

Group 1 - The core viewpoint of the news is that Meditech experienced a decline in stock price and trading volume, with significant changes in financing and stockholder metrics [1][2]. - On January 6, Meditech's stock fell by 0.65%, with a trading volume of 274 million yuan. The financing buy-in amount was 21.23 million yuan, while the financing repayment was 32.91 million yuan, resulting in a net financing buy of -11.68 million yuan [1]. - As of January 6, the total balance of margin trading for Meditech was 268 million yuan, with a financing balance of 267 million yuan, accounting for 5.71% of the circulating market value, indicating a high level compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Meditech increased to 38,900, a rise of 7.17%, while the average circulating shares per person decreased by 6.69% to 7,864 shares [2]. - For the period from January to September 2025, Meditech reported operating revenue of 22.3 million yuan, a year-on-year decrease of 38.13%, while the net profit attributable to the parent company was 34.27 million yuan, showing a year-on-year increase of 120.49% [2]. - Meditech has cumulatively distributed dividends of 71.36 million yuan since its A-share listing, with no dividends distributed in the last three years [3].

证券代码：603990 证券简称：麦迪科技 公告编号：2025-091 苏州麦迪斯顿医疗科技股份有限公司 关于使用部分闲置募集资金进行现金管理赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第四届董事会第三十一次会议、第四届监事会第十五次会议，审议通 过了《关于使用部分闲置募集资金进行现金管理的议案》，同意公司在确保不影 响募集资金投资项目进度和募集资金安全的前提下，对暂时闲置的部分募集资金 不超过人民币 2 亿元（包含本数）进行现金管理，余额在上述额度内，资金可以 滚动使用，用于购买单笔期限最长不超过 12 个月（含 12 个月）的结构性存款等 安全性高的保本型产品，不得用于证券投资。公司董事会、监事会及保荐机构已 分别对前述事项发表了同意的意见。具体内容详见公司于 2025 年 4 月 30 日披露 的《关于使用部分闲置募集资金进行现金管理的公告》(公告编号：2025-025)。 一、 公司募集资金现金管理到期赎回情况 公 ...

Group 1 - The company received a resignation letter from independent director Mr. Li Dong due to adjustments in the corporate governance structure, effective immediately upon delivery to the board [2][3] - The company held a staff representative meeting on December 26, 2025, where Ms. Huang Chunmeng was elected as the employee director of the fourth board, with her term starting from the approval date of the amendment to the articles of association [2][4] - Mr. Li Dong's resignation will not affect the minimum number of board members required by law and will not adversely impact the company's normal operations [2] Group 2 - The company decided to terminate the fourth employee stock ownership plan and change the purpose of repurchased shares, resulting in the cancellation of 1,037,300 shares, which is 0.3387% of the total share capital [7] - Following the cancellation, the total share capital will decrease from 306,282,731 shares to 305,245,431 shares, and the registered capital will reduce from 306,282,731 yuan to 305,245,431 yuan [7] - The company notified creditors about the capital reduction, allowing them to claim debts within specified timeframes [9][10] Group 3 - The fourth board meeting was held on December 29, 2025, where the board approved the adjustment of the specialized committee members [11] - Mr. Ren Xiaojun was elected as the chairman of the remuneration and assessment committee and a member of the audit committee, effective immediately [11] - The meeting was attended by all five board members, and the resolutions passed were deemed legally valid [11][13] Group 4 - The third extraordinary general meeting of shareholders was held on December 29, 2025, with all resolutions passed without any objections [15][16] - The meeting approved the cancellation of the supervisory board and the amendments to the articles of association, allowing the audit committee to assume the supervisory functions [18][20] - The meeting also approved the reappointment of Zhonghui Certified Public Accountants as the auditing firm for the 2025 fiscal year [22][23]

Core Viewpoint - The company, Madi Technology (603990), announced the election of Ms. Huang Chunmeng as the employee director of the fourth board of directors during the employee representative meeting scheduled for December 26, 2025 [1] Group 1 - The employee representative meeting is set to take place on December 26, 2025 [1] - Ms. Huang Chunmeng has been elected as the employee director [1]

证券代码：603990 证券简称：麦迪科技 公告编号：2025-088 苏州麦迪斯顿医疗科技股份有限公司 关于注销部分回购股份并减少注册资本暨通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、通知债权人的原因 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）于 2025 年 12 月 18 日召开第四届董事会第三十九次会议、于 2025 年 12 月 29 日召开了 2025 年 第三次临时股东大会，审议通过了《关于终止公司第四期员工持股计划、变更回 购股份用途并注销股票的议案》，基于对公司长期价值的认可，为更好地维护保 障公司、员工及广大投资者的利益，公司将终止实施第四期员工持股计划，变更 回购专用账户部分回购股份用途并注销该部分股票，对应股份数量为 1,037,300 股，占公司当前总股本的 0.3387%。本次回购注销完成后，公司总股本将由 306,282,731 股减少为 305,245,431 股，注册资本将由 306,282,731 元减少为 305,245,431 元，具体股份变动情况以注 ...

证券代码：603990 证券简称：麦迪科技 公告编号：2025-089 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）于近日收到公 司独立董事李东先生的书面辞职报告。因公司治理结构调整，李东先生申请辞去 公司第四届董事会独立董事及董事会专门委员会委员，该辞职报告自送达公司董 事会之日起生效，李东先生辞职后不再担任公司任何职务。 公司于 2025 年 12 月 26 日召开职工代表大会并做出决议，选举皇春萌女 士担任公司第四届董事会职工董事，任期自公司 2025 年第三次临时股东大会审 议通过《关于取消监事会并修订<公司章程>的议案》之日起至公司第四届董事会 任期届满之日止。 苏州麦迪斯顿医疗科技股份有限公司 关于公司独立董事辞任暨选举职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 根据《中华人民共和国公司法》（以下简称"《公司法》"）以及中国证监会《关 于新<公司法>配套制度规则实施相关过渡期安排》等相关规定，公司于2025年12 月29日召开2025年第三次临时股东大会，审议并通过了《公 ...